亚甲蓝在感染性休克中的应用——我们武器库中的一种新型武器：效用研究是否凸显了其无用性？
Methylene Blue in Septic Shock-A Novel Weapon in Our Arsenal: Are Utility Studies Highlighting its Futility?
作者信息
Angadi Varun M, Jindal Atul
机构信息
Department of Pediatrics, AIIMS, Raipur, Chhattisgarh, India.
出版信息
Indian J Crit Care Med. 2024 Jan;28(1):89. doi: 10.5005/jp-journals-10071-24589.
Abstract
Angadi VM, Jindal A. Methylene Blue in Septic Shock-A Novel Weapon in Our Arsenal: Are Utility Studies Highlighting its Futility? Indian J Crit Care Med 2024;28(1):89.
摘要
安加迪·VM、金达尔·A。亚甲蓝在感染性休克中的应用——我们武器库中的一种新型武器：效用研究是否凸显了其无用性？《印度重症监护医学杂志》2024年；28(1):89。
相似文献
1
Methylene Blue in Septic Shock-A Novel Weapon in Our Arsenal: Are Utility Studies Highlighting its Futility?亚甲蓝在感染性休克中的应用——我们武器库中的一种新型武器：效用研究是否凸显了其无用性？
Indian J Crit Care Med. 2024 Jan;28(1):89. doi: 10.5005/jp-journals-10071-24589.
2
Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study.静脉注射亚甲蓝能否改善难治性感染性休克患者的血流动力学及预后？一项观察性研究。
Indian J Crit Care Med. 2023 Sep;27(9):669-674. doi: 10.5005/jp-journals-10071-24535.
3
Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock.亚甲蓝持续延长输注治疗难治性感染性休克
Indian J Crit Care Med. 2020 Mar;24(3):206-207. doi: 10.5005/jp-journals-10071-23376.
4
Author Response.作者回复。
Indian J Crit Care Med. 2024 Jan;28(1):90-91. doi: 10.5005/jp-journals-10071-24605.
5
Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock.亚甲蓝联合去甲肾上腺素对实验性脓毒症休克肠道微循环的影响
Clin Hemorheol Microcirc. 2014;58(1):97-105. doi: 10.3233/CH-141874.
6
To C or not to C? Designing a Pragmatic Trial to Deploy a Novel Immunomodulatory Therapy to Fight Organ Dysfunction in Sepsis.是选择C还是不选C？设计一项务实试验以应用新型免疫调节疗法对抗脓毒症中的器官功能障碍。
Indian J Crit Care Med. 2024 Mar;28(3):311. doi: 10.5005/jp-journals-10071-24636.
7
Mottling Incidence and Mottling Score According to Arterial Lactate Level in Septic Shock Patients.脓毒症休克患者中根据动脉血乳酸水平的皮肤斑纹发生率及皮肤斑纹评分
Indian J Crit Care Med. 2020 Aug;24(8):672-676. doi: 10.5005/jp-journals-10071-23531.
8
Methylene blue administration in septic shock: a clinical trial.亚甲蓝用于感染性休克的临床试验
Crit Care Med. 1995 Feb;23(2):259-64. doi: 10.1097/00003246-199502000-00010.
9
Methylene blue for the treatment of septic shock.亚甲蓝治疗感染性休克。
Pharmacotherapy. 2010 Jul;30(7):702-15. doi: 10.1592/phco.30.7.702.
10
Blood Lactate Level and the Predictor of Death in Non-shock Septic Patients.非休克型脓毒症患者的血乳酸水平与死亡预测因素
Indian J Crit Care Med. 2023 Feb;27(2):93-100. doi: 10.5005/jp-journals-10071-24404.
引用本文的文献
1
Author Response.作者回复。
Indian J Crit Care Med. 2024 Jan;28(1):90-91. doi: 10.5005/jp-journals-10071-24605.
本文引用的文献
1
Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study.静脉注射亚甲蓝能否改善难治性感染性休克患者的血流动力学及预后？一项观察性研究。
Indian J Crit Care Med. 2023 Sep;27(9):669-674. doi: 10.5005/jp-journals-10071-24535.
2
Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.非儿茶酚胺类血管升压药治疗成人感染性休克——来自随机临床试验的荟萃分析和试验序贯分析的证据
J Intensive Care. 2020 Oct 31;8(1):83. doi: 10.1186/s40560-020-00500-0.
3
Management of Refractory Vasodilatory Shock.难治性血管扩张性休克的处理。
Chest. 2018 Aug;154(2):416-426. doi: 10.1016/j.chest.2017.12.021. Epub 2018 Jan 9.
4
Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock.比较隐匿性休克与显性休克患者进行早期脓毒症复苏的结局。
Resuscitation. 2011 Oct;82(10):1289-93. doi: 10.1016/j.resuscitation.2011.06.015. Epub 2011 Jun 23.
5
Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress.危重病期间的交感神经过度刺激：肾上腺素能应激的不良效应。
J Intensive Care Med. 2009 Sep-Oct;24(5):293-316. doi: 10.1177/0885066609340519. Epub 2009 Aug 23.
Zotero 插件